BACK TO FUNDAMENTALS

Eiko Lifesciences Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Dec 2018

Auditor and Management Disclosures and Notes for the quarterly results dated 31 Dec 2018

1. The above Standalone Financial Results which are published in accordance with the regulation 33 of the Securities and Exchange Board Of India (Listing obligations & Disclosure Requirements) Regulations. 2015 have been reviewed and recommended by Audit Committee and has been approved by the Board of Directors at its Meeting held on 11th January, 2019.

2. The company has adopted Indian Accounting Standard (Ind AS) effective from 1st April' 2017 (Transition date being 1st April' 2016) and accordingly the financial results for the quarter 30th September 2018 have been prepared in accordance with the recognition and measurement principles laid down in Ind As-34 Interim Financial Reporting prescribed under section 133 of the Companies Act' 2013

3. The company has only one business segment.

4. Previous quarter figures have been regrouped / reclassified wherever necessary, to make them comparable.

Laxmikant Kabra
Director